Related Experiment Video
Updated: Jan 16, 2026

Comparing Bibliometric Analysis Using PubMed, Scopus, and Web of Science Databases
Published on: October 24, 2019
Two Surveys, 16 Years Apart: Comparing Traditional and Complementary Medicine Use by Children With Cancer in Jordan
Murad Sawalha1, Anwar Alnaasan2, Anas Alsharawneh3,4
1Department of Maternal, Child and Family Health Nursing, Faculty of Nursing, The Hashemite University, Zarqa, Jordan.
Background:
Traditional and complementary medicine (T&CM) is commonly used by children with cancer alongside conventional treatments. However, data on its use in Jordan remain limited. This study aimed to assess the current prevalence, types, motivations, and disclosure rates of T&CM use in Jordan, and to compare these findings with those from the original 2008 study conducted in the same setting.
Methods:
A cross-sectional study was conducted in the pediatric oncology department at King Hussein Cancer Center between November 2023 and May 2024. A brief proxy-report T&CM questionnaire with evidence of validity and reliability was used.
Results:
A total of 85 patients participated (response rate = 85%). Overall, 29.4% reported T&CM use, primarily for perceived safety (52%), managing cancer-related symptoms (44%), and potential therapeutic benefit (40%). Nutritional (68%) and psychological (24%) approaches were the most used modalities. Disclosure of T&CM use to healthcare providers was reported by 75% of users. Reasons for non-use included a lack of recommendation by healthcare providers and limited awareness. A statistically significant association was found between T&CM use and current therapy stage, with higher use among patients in active treatment. No other demographic or clinical variables were significantly associated with T&CM use.
Conclusion:
Compared to earlier findings, this study shows a lower prevalence of T&CM use and a higher disclosure rate, suggesting improved communication and awareness. Parents used T&CM to complement conventional care rather than as an alternative. These findings underscore the importance of integrating discussions about T&CM into pediatric oncology care to support safe and informed use.
Related Concept Videos
Cancer Survival Analysis
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Comparing the Survival Analysis of Two or More Groups
Pharmacokinetics in Pediatric Patients: Drug Distribution